Because, unlike you, she can read data?
"evidence from other states clearly show that Prescription Drug Affordability Boards (“PDABs”) do not achieve this goal. They are expensive undertakings that other states have either repealed or are considering repealing due to costs and ineffectiveness.”
"evidence from other states clearly show that Prescription Drug Affordability Boards (“PDABs”) do not achieve this goal. They are expensive undertakings that other states have either repealed or are considering repealing due to costs and ineffectiveness.”
May 21, 2026 at 7:14 PM
Because, unlike you, she can read data?
"evidence from other states clearly show that Prescription Drug Affordability Boards (“PDABs”) do not achieve this goal. They are expensive undertakings that other states have either repealed or are considering repealing due to costs and ineffectiveness.”
"evidence from other states clearly show that Prescription Drug Affordability Boards (“PDABs”) do not achieve this goal. They are expensive undertakings that other states have either repealed or are considering repealing due to costs and ineffectiveness.”
PDABs weren’t built to protect patients—they were built to look like reform.
Now their sham processes mirror RFK Jr.'s gutting of public input at HHS.
Different timelines, same result: patients excluded.
tjoe.co/ls1fq8
#PDAB #HealthPolicy #HealthJustice #HIVsky
Now their sham processes mirror RFK Jr.'s gutting of public input at HHS.
Different timelines, same result: patients excluded.
tjoe.co/ls1fq8
#PDAB #HealthPolicy #HealthJustice #HIVsky
PDAB Chicanery: How Drug Affordability Boards Are Undermining Public Engagement
PDABs say they’re helping patients. In reality, they’re muzzling public input and playing politics with life-saving medications.
tjoe.co
April 2, 2025 at 2:01 PM
PDABs weren’t built to protect patients—they were built to look like reform.
Now their sham processes mirror RFK Jr.'s gutting of public input at HHS.
Different timelines, same result: patients excluded.
tjoe.co/ls1fq8
#PDAB #HealthPolicy #HealthJustice #HIVsky
Now their sham processes mirror RFK Jr.'s gutting of public input at HHS.
Different timelines, same result: patients excluded.
tjoe.co/ls1fq8
#PDAB #HealthPolicy #HealthJustice #HIVsky
"[], I am vetoing HB483 and SB271 because evidence from other states clearly show that Prescription Drug Affordability Boards (“PDABs”) do not achieve this goal. They are expensive undertakings that other states have either repealed or are considering repealing due to costs and ineffectiveness.”
May 20, 2026 at 1:34 AM
"[], I am vetoing HB483 and SB271 because evidence from other states clearly show that Prescription Drug Affordability Boards (“PDABs”) do not achieve this goal. They are expensive undertakings that other states have either repealed or are considering repealing due to costs and ineffectiveness.”
Governor Youngkin should veto Prescription Drug Affordability Boards, again
Other states with PDABs in operation showcase this concept’s inability to lower patient prices.
Other states with PDABs in operation showcase this concept’s inability to lower patient prices.
Governor Youngkin should veto Prescription Drug Affordability Boards, again
Other states with PDABs in operation showcase this concept’s inability to lower patient prices.
cardinalnews.org
March 11, 2025 at 7:59 AM
Governor Youngkin should veto Prescription Drug Affordability Boards, again
Other states with PDABs in operation showcase this concept’s inability to lower patient prices.
Other states with PDABs in operation showcase this concept’s inability to lower patient prices.
I like the idea of finding practical ways to make expensive drugs more affordable. PDABs are something to keep in mind, if they can actually deliver savings without creating access problems.
August 7, 2026 at 9:38 PM
I like the idea of finding practical ways to make expensive drugs more affordable. PDABs are something to keep in mind, if they can actually deliver savings without creating access problems.
CANN wishes to express our gratitude to Gov. Youngkin for his veto of HB1724. #PDABs repeat the problems in the Inflation Reduction Act, incentivizing upward wealth redistribution at the expense of healthcare access.
Read @nytimes.com piece: www.nytimes.com/2025/01/16/h...
Read @nytimes.com piece: www.nytimes.com/2025/01/16/h...
Insulin Prices Dropped. But Some Poor Patients Are Paying More.
A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for low-income health clinics.
www.nytimes.com
March 26, 2025 at 8:33 PM
CANN wishes to express our gratitude to Gov. Youngkin for his veto of HB1724. #PDABs repeat the problems in the Inflation Reduction Act, incentivizing upward wealth redistribution at the expense of healthcare access.
Read @nytimes.com piece: www.nytimes.com/2025/01/16/h...
Read @nytimes.com piece: www.nytimes.com/2025/01/16/h...
Louisiana must reject #SB401 and save patients from hardships imposed by Prescription Drug Affordability Boards (PDABs). Otherwise, patients will suffer from flawed policies like Upper Payment Limits (UPLs) — price caps that limit medication access and supply and increase out-of-pocket costs.
April 1, 2026 at 5:11 PM
Louisiana must reject #SB401 and save patients from hardships imposed by Prescription Drug Affordability Boards (PDABs). Otherwise, patients will suffer from flawed policies like Upper Payment Limits (UPLs) — price caps that limit medication access and supply and increase out-of-pocket costs.
District Court Dismisses Manufacturer Lawsuit Challenging Colorado Price Setting for Prescription Drug
District Court Dismisses Manufacturer Lawsuit Challenging Colorado Price Setting for Prescription Drug
There are currently six states with active Prescription Drug Affordability Boards (PDABs) — Colorado, Maryland, Washington, Oregon, New...
www.jdsupra.com
May 5, 2025 at 4:14 PM
District Court Dismisses Manufacturer Lawsuit Challenging Colorado Price Setting for Prescription Drug
States are leading in the fight to make drug prices more affordable. Our founder, @gabygoldstein.bsky.social spoke with @bloomberglaw.com about new prescription drug affordability boards (PDABs) legislation that is moving in Virginia.
Read more: news.bloomberglaw.com/health-law-a...
Read more: news.bloomberglaw.com/health-law-a...
Virginia Pushes for Board Tying Drug Costs to Medicare Prices
High prescription drug costs are facing greater oversight at the state level as Virginia lawmakers charge ahead with measures to lower prices, joining a handful of states already at odds with the phar...
news.bloomberglaw.com
March 2, 2026 at 7:00 PM
States are leading in the fight to make drug prices more affordable. Our founder, @gabygoldstein.bsky.social spoke with @bloomberglaw.com about new prescription drug affordability boards (PDABs) legislation that is moving in Virginia.
Read more: news.bloomberglaw.com/health-law-a...
Read more: news.bloomberglaw.com/health-law-a...
Manasi Vaidya of GlobalData: Exploring the growing role of state Prescription Drug Affordability Boards (PDABs) in deciding what drugs are covered by a U.S. state, with a focus on therapies for cystic fibrosis and other rare disorders.
December 4, 2024 at 3:44 PM
Manasi Vaidya of GlobalData: Exploring the growing role of state Prescription Drug Affordability Boards (PDABs) in deciding what drugs are covered by a U.S. state, with a focus on therapies for cystic fibrosis and other rare disorders.
NEW BLOG: "PDAB Chicanery: How Drug Affordability Boards Are Undermining Public Engagement"
From Maryland's last-minute document dumps to Colorado's refusal to analyze patient impacts, PDABs are sidelining the very people who have the most at stake.
"We shouldn't be playing with people's lives."
From Maryland's last-minute document dumps to Colorado's refusal to analyze patient impacts, PDABs are sidelining the very people who have the most at stake.
"We shouldn't be playing with people's lives."
PDAB Chicanery: How Drug Affordability Boards Are Undermining Public Engagement — HIV-HCV Co-Infection Watch
Prescription Drug Affordability Boards (PDABs) across the country are playing a dangerous game with public engagement—one where they keep changing the rules and moving the goalposts. From inadequate n...
www.hiv-hcv-watch.com
April 1, 2025 at 12:26 AM
NEW BLOG: "PDAB Chicanery: How Drug Affordability Boards Are Undermining Public Engagement"
From Maryland's last-minute document dumps to Colorado's refusal to analyze patient impacts, PDABs are sidelining the very people who have the most at stake.
"We shouldn't be playing with people's lives."
From Maryland's last-minute document dumps to Colorado's refusal to analyze patient impacts, PDABs are sidelining the very people who have the most at stake.
"We shouldn't be playing with people's lives."
... I am vetoing HB483 and SB271 because evidence from other states clearly show that Prescription Drug Affordability Boards (“PDABs”) do not achieve this goal. They are expensive undertakings that other states have either repealed or are considering repealing due to costs and ineffectiveness.”
I'm not shocked at all. This is who Spanberger is, folks.
You'll keep seeing it more and more.
You'll keep seeing it more and more.
Gov. Abigail Spanberger killed a proposal Tuesday that would have created a Virginia Prescription Drug Affordability Board, shelving a years-long bipartisan effort aimed at lowering prescription drug costs through state oversight and payment limits.
virginiamercury.com/2026/05/19/s...
virginiamercury.com/2026/05/19/s...
May 21, 2026 at 7:06 PM
... I am vetoing HB483 and SB271 because evidence from other states clearly show that Prescription Drug Affordability Boards (“PDABs”) do not achieve this goal. They are expensive undertakings that other states have either repealed or are considering repealing due to costs and ineffectiveness.”
#LGBTQ+ advocacy leaders from MD and VA raise concerns about #PDABs - boards that review drug costs but may limit access to vital medications for people living with #HIV and chronic conditions. "We need solutions that make meds affordable without sacrificing access." #HealthEquity
PDAB: A mysterious acronym that could affect your health
We must make medications affordable without sacrificing access
buff.ly
May 12, 2025 at 8:01 PM
#LGBTQ+ advocacy leaders from MD and VA raise concerns about #PDABs - boards that review drug costs but may limit access to vital medications for people living with #HIV and chronic conditions. "We need solutions that make meds affordable without sacrificing access." #HealthEquity
How are pharma #HEOR teams informing industry responses to developments like the #IRA, state #PDABs, and rules for sharing economic evidence with payers?
Read CEVR’s report exploring the results of our new national survey of industry HEOR leaders to find out: tinyurl.com/ywjsntyy
Read CEVR’s report exploring the results of our new national survey of industry HEOR leaders to find out: tinyurl.com/ywjsntyy
The Tufts-CEVR HEOR Leaders Survey: Health Policy Challenges and Opportunities - Center for the Evaluation of Value and Risk in Health
cevr.tuftsmedicalcenter.org
January 21, 2026 at 1:35 PM
How are pharma #HEOR teams informing industry responses to developments like the #IRA, state #PDABs, and rules for sharing economic evidence with payers?
Read CEVR’s report exploring the results of our new national survey of industry HEOR leaders to find out: tinyurl.com/ywjsntyy
Read CEVR’s report exploring the results of our new national survey of industry HEOR leaders to find out: tinyurl.com/ywjsntyy
Are you an Oregon resident currently taking any of the 27 medications the Prescription Drug Affordability Board is reviewing? They need to hear from you! Use the link from our partners at the PIC to learn about this opportunity and more!
Link: eachpic.org/pic-voices/
#PDABs
Link: eachpic.org/pic-voices/
#PDABs
April 15, 2025 at 11:13 PM
Are you an Oregon resident currently taking any of the 27 medications the Prescription Drug Affordability Board is reviewing? They need to hear from you! Use the link from our partners at the PIC to learn about this opportunity and more!
Link: eachpic.org/pic-voices/
#PDABs
Link: eachpic.org/pic-voices/
#PDABs
$28M into drug-price boards since 2019 and still no patient UPL savings. Colorado’s cap is in court, Maryland’s does not hit commercial pockets yet. A board that never moves the counter is not bargaining.
www.tiicann.org/blog/pdabs-s...
www.tiicann.org/blog/pdabs-s...
PDABs Have Spent $28M — and Saved Patients Nothing
Since 2019, PDABs have cost states $28 million, held hundreds of meetings, & delivered zero savings for patients. CANN breaks down the numbers and next steps.
www.tiicann.org
September 4, 2026 at 4:45 PM
$28M into drug-price boards since 2019 and still no patient UPL savings. Colorado’s cap is in court, Maryland’s does not hit commercial pockets yet. A board that never moves the counter is not bargaining.
www.tiicann.org/blog/pdabs-s...
www.tiicann.org/blog/pdabs-s...
CANN’s tally is the part that should travel: $28 million spent, 221 meetings, zero patient-facing UPL savings. Affordability is what the patient pays and whether the script fills, not how many hearings got scheduled.
www.tiicann.org/blog/pdabs-s...
www.tiicann.org/blog/pdabs-s...
PDABs Have Spent $28M — and Saved Patients Nothing
Since 2019, PDABs have cost states $28 million, held hundreds of meetings, & delivered zero savings for patients. CANN breaks down the numbers and next steps.
www.tiicann.org
September 4, 2026 at 4:33 PM
CANN’s tally is the part that should travel: $28 million spent, 221 meetings, zero patient-facing UPL savings. Affordability is what the patient pays and whether the script fills, not how many hearings got scheduled.
www.tiicann.org/blog/pdabs-s...
www.tiicann.org/blog/pdabs-s...
We need more solutions to the prescription drug affordability problem, not fewer. PDABs are one way states can push for more reasonable prices.
September 3, 2026 at 8:34 AM
We need more solutions to the prescription drug affordability problem, not fewer. PDABs are one way states can push for more reasonable prices.
This makes me think of PDABs differently. Maybe the useful question isn't how do we make every prescription cheaper? but which drugs are creating the biggest affordability problems?
August 27, 2026 at 11:56 AM
This makes me think of PDABs differently. Maybe the useful question isn't how do we make every prescription cheaper? but which drugs are creating the biggest affordability problems?
via Partnership For Safe Medicines - How much have PDABs spent to date? $28mm over 5 years, with not a single patient ever seeing the financial benefits of an Upper Payment Limit: https://www.safemedicines.org/wp-content/uploads/2026/06/2026-update-PDAB-infographic-numbers-v2-1.pdf
August 5, 2026 at 1:35 PM
via Partnership For Safe Medicines - How much have PDABs spent to date? $28mm over 5 years, with not a single patient ever seeing the financial benefits of an Upper Payment Limit: https://www.safemedicines.org/wp-content/uploads/2026/06/2026-update-PDAB-infographic-numbers-v2-1.pdf
It's worth looking at Prescription Drug Affordability Boards (PDABs) and what they can do to help patients cope with some of the financial struggles they have with healthcare. By assessing if prescription drugs are overpriced, they can mitigate some issues that a lot of people are dealing with.
August 4, 2026 at 6:02 AM
It's worth looking at Prescription Drug Affordability Boards (PDABs) and what they can do to help patients cope with some of the financial struggles they have with healthcare. By assessing if prescription drugs are overpriced, they can mitigate some issues that a lot of people are dealing with.
Transparency is always welcome, especially in matters of public interest, such as healthcare. PDABs should use transparency as a tool in their efforts to help monitor and lower prescription drug prices.
August 3, 2026 at 6:34 AM
Transparency is always welcome, especially in matters of public interest, such as healthcare. PDABs should use transparency as a tool in their efforts to help monitor and lower prescription drug prices.